节点文献

非离子表面活性剂逆转肿瘤细胞多药耐药性的机制

Study on the reversal of cancer cell’s multidrug resistance by non-ionic surfactant and its mechanism

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 武建毅刘岽唐亮谈立松

【Author】 WU Jian-yi, LIU Dong, TANG Liang, et al. Department of Immunotherapy of Lung Cancer(the Central Laboratory),Shanghai Pulmonary Hospital,Shanghai 200433,China

【机构】 上海市肺科医院免疫治疗科上海市肺科医院免疫治疗科 上海200433上海200433

【摘要】 目的探讨非离子表面活性剂聚氧乙烯醚﹑聚乙二醇300﹑曲拉通X100对肺癌耐药细胞A549/DDP(耐顺铂)多药耐药性的逆转及其机制。方法用四氮唑盐(MTT)法进行体外耐药逆转实验,Westernblot检测P-gp(P-糖蛋白)蛋白的表达。结果①合用非离子型表活剂前后,A549/DDP对化疗药物阿霉素、顺铂、丝裂霉素、5-氟尿嘧啶、依托泊甙和长春新碱的敏感性显著增加(各组都为P<0.01);②三种非离子型表面活性剂能抑制P-gp蛋白的表达。结论三种非离子表面活性剂具有逆转A549/DDP耐药性的作用,逆转机制与其抑制P-gp蛋白的表达有关。

【Abstract】 Objective To discuss whether the non-ionic surfactant (CremophorEL, PEG300, TritonX-100)can reverse the miltidrug resistance(MDR) of the lung cancer cell strian A549/DDP or not and their mechanism. Methods The reversing drug resistance was studied by MTT, expression of P-gp was detected by Western blot.Results (1)MTT cytotoxic assay revealed that the sensitivities of A549/DDP cells to chemotherapy drugs were significant changed according to presence or absence of non-ionic surfactant(P<0.01); (2)The three non-ionic surfactant can inhibit expression of p-gp.Conclusion The three non-ionic surfactant can reverse the MDR of the lung cancer cell strian A549/DDP,inhibiting expression of p-gp maybe its mechanism.

  • 【文献出处】 实用医药杂志 ,Practical Journal of Medicine & Pharmacy , 编辑部邮箱 ,2007年01期
  • 【分类号】R730.5
  • 【下载频次】211
节点文献中: 

本文链接的文献网络图示:

本文的引文网络